Skip to main content

Advertisement

Log in

The expression of glutamine-metabolism-related proteins in breast phyllodes tumors

  • Research Article
  • Published:
Tumor Biology

Abstract

The aim of this study was to investigate the expression of glutamine-metabolism-related proteins according to the histologic grade of phyllodes tumors (PTs) and to assess its clinical implication. We generated tissue microarrays of 224 PTs and performed immunohistochemical staining and western blot analysis of glutamine-metabolism-related molecules, including GLS1, GDH, and ASCT2. The associations between immunohistochemical results and clinicopathologic parameters were evaluated. The expression of GLS1 (p < 0.001), GDH (p < 0.001), and ASCT2 (p = 0.005) in stromal components significantly increased with worsening PT histological grade. GDH expression in epithelial components significantly increased in high-grade PT (p = 0.026). In western blot, stromal expression of GLS1, GDH, and ASCT2 increased as histologic grade increased. By univariate analysis, stromal GLS1 expression (p = 0.022) and stromal GDH expression (p = 0.009) were independent predictors of shorter DFS. Stromal GLS1 expression (p < 0.001) and stromal GDH expression (p < 0.001) were independent predictors of shorter OS. This study demonstrated that the stromal expression of the glutamine-metabolism-related proteins GLS1, GDH, ASCT2 increases with worsening histological PT grade.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Warburg O. On the origin of cancer cells. Science. 1956;123:309–14.

    Article  CAS  PubMed  Google Scholar 

  2. DeBerardinis RJ, Cheng T. Q’s next: the diverse functions of glutamine in metabolism, cell biology and cancer. Oncogene. 2010;29:313–24.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  3. Collins CL, Wasa M, Souba WW, Abcouwer SF. Regulation of glutamine synthetase in human breast carcinoma cells and experimental tumors. Surgery. 1997;122:451–63. discussion 63–4.

    Article  CAS  PubMed  Google Scholar 

  4. Friday E, Oliver 3rd R, Welbourne T, Turturro F. Glutaminolysis and glycolysis regulation by troglitazone in breast cancer cells: relationship to mitochondrial membrane potential. J Cell Physiol. 2011;226:511–9.

    Article  CAS  PubMed  Google Scholar 

  5. McGivan JD, Bungard CI. The transport of glutamine into mammalian cells. Front Biosci. 2007;12:874–82.

    Article  CAS  PubMed  Google Scholar 

  6. Curthoys NP, Watford M. Regulation of glutaminase activity and glutamine metabolism. Annu Rev Nutr. 1995;15:133–59.

    Article  CAS  PubMed  Google Scholar 

  7. Dang CV. Glutaminolysis: supplying carbon or nitrogen or both for cancer cells? Cell Cycle. 2010;9:3884–6.

    Article  CAS  PubMed  Google Scholar 

  8. Tavassoli FA, Devilee P, International Agency for Research on Cancer (IAPS), World Health Organization. Pathology and genetics of tumours of the breast and female genital organs. Lyon: IAPS; 2003.

    Google Scholar 

  9. Alo PL, Visca P, Botti C, Galati GM, Sebastiani V, Andreano T, et al. Immunohistochemical expression of human erythrocyte glucose transporter and fatty acid synthase in infiltrating breast carcinomas and adjacent typical/atypical hyperplastic or normal breast tissue. Am J Clin Pathol. 2001;116:129–34.

    Article  CAS  PubMed  Google Scholar 

  10. Brown RS, Wahl RL. Overexpression of Glut-1 glucose transporter in human breast cancer. An immunohistochemical study. Cancer. 1993;72:2979–85.

    Article  CAS  PubMed  Google Scholar 

  11. Grover-McKay M, Walsh SA, Seftor EA, Thomas PA, Hendrix MJ. Role for glucose transporter 1 protein in human breast cancer. Pathol Oncol Res. 1998;4:115–20.

    Article  CAS  PubMed  Google Scholar 

  12. Stackhouse BL, Williams H, Berry P, Russell G, Thompson P, Winter JL, et al. Measurement of glut-1 expression using tissue microarrays to determine a race specific prognostic marker for breast cancer. Breast Cancer Res Treat. 2005;93:247–53.

    Article  CAS  PubMed  Google Scholar 

  13. Younes M, Brown RW, Mody DR, Fernandez L, Laucirica R. GLUT1 expression in human breast carcinoma: correlation with known prognostic markers. Anticancer Res. 1995;15:2895–8.

    CAS  PubMed  Google Scholar 

  14. Yang C, Sudderth J, Dang T, Bachoo RM, McDonald JG, DeBerardinis RJ. Glioblastoma cells require glutamate dehydrogenase to survive impairments of glucose metabolism or Akt signaling. Cancer Res. 2009;69:7986–93.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  15. Noguchi S, Motomura K, Inaji H, Imaoka S, Koyama H. Clonal analysis of fibroadenoma and phyllodes tumor of the breast. Cancer Res. 1993;53:4071–4.

    CAS  PubMed  Google Scholar 

  16. Sawyer EJ, Hanby AM, Ellis P, Lakhani SR, Ellis IO, Boyle S, et al. Molecular analysis of phyllodes tumors reveals distinct changes in the epithelial and stromal components. Am J Pathol. 2000;156:1093–8.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  17. Gao P, Tchernyshyov I, Chang TC, Lee YS, Kita K, Ochi T, et al. c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism. Nature. 2009;458:762–5.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  18. Sawyer EJ, Poulsom R, Hunt FT, Jeffery R, Elia G, Ellis IO, et al. Malignant phyllodes tumours show stromal overexpression of c-myc and c-kit. J Pathol. 2003;200:59–64.

    Article  CAS  PubMed  Google Scholar 

  19. Kwon JE, Jung WH, Koo JS. The expression of metabolism-related proteins in phyllodes tumors. Tumour Biol. 2013;34:115–24.

    Article  CAS  PubMed  Google Scholar 

  20. Camp RL, Charette LA, Rimm DL. Validation of tissue microarray technology in breast carcinoma. Lab Invest. 2000;80:1943–9.

    Article  CAS  PubMed  Google Scholar 

  21. Aft RL, Zhang FW, Gius D. Evaluation of 2-deoxy-d-glucose as a chemotherapeutic agent: mechanism of cell death. Br J Cancer. 2002;87:805–12.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  22. Morris DI, Robbins JD, Ruoho AE, Sutkowski EM, Seamon KB. Forskolin photoaffinity labels with specificity for adenylyl cyclase and the glucose transporter. J Biol Chem. 1991;266:13377–84.

    CAS  PubMed  Google Scholar 

  23. Niculescu-Duvaz I. Glufosfamide (Baxter Oncology). Curr Opin Investig Drugs. 2002;3:1527–32.

    CAS  PubMed  Google Scholar 

  24. Subbarayan PR, Wang PG, Lampidis TJ, Ardalan B, Braunschweiger P. Differential expression of Glut 1 mRNA and protein levels correlates with increased sensitivity to the glyco-conjugated nitric oxide donor (2-glu-SNAP) in different tumor cell types. J Chemother. 2008;20:106–11.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF), funded by the Ministry of Education, Science and Technology (2012R1A1A1002886).

Conflicts of interest

None

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ja Seung Koo.

Electronic supplementary materials

Below is the link to the electronic supplementary material.

ESM 1

(DOC 68 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kim, S., Jung, W.H. & Koo, J.S. The expression of glutamine-metabolism-related proteins in breast phyllodes tumors. Tumor Biol. 34, 2683–2689 (2013). https://doi.org/10.1007/s13277-013-0819-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13277-013-0819-7

Keywords

Navigation